Epithelium and mesenchyme, two tissue types virtually found in every organ,
are endowed with fundamentally different functional properties. Active mot
ility, a capability that is limited to the mesenchymal repertoire, is the p
rincipal characteristic that distinguishes them. During embryonic developme
nt, conversions from epithelium to mesenchyme and from mesenchyme to epithe
lium normally occur, allowing morphogenetic processes and tissue remodellin
g to take place. However, there is now increasing evidence that the modulat
ion between the epithelial and the mesenchymal phenotypes is not limited to
embryonic life. Indeed, the pathogenesis of some adult diseases seems to i
mplicate an inappropriate activation of this change. On the other hand, fai
lure of normally occurring embryonic epithelial-mesenchymal interconversion
s could result in the development of some pathologies. It is now possible t
o study some molecular events underlying these phenotype transitions, since
several biological agents implicated in the epithelial-mesenchymal interco
nversion, such as growth factors, extracellular matrix components and their
receptors, transcription factors and oncogenes have been identified. The m
alignant potential of some oncogenes seems to express itself through the di
sruption of the mechanisms involved in the maintenance of the epithelial ph
enotype while, on the other hand, some observations suggest the existence o
f regulatory genes able to counteract the action of oncogenes by restoring
epithelial characteristics. Therefore, the manipulation of the tissue pheno
type could represent a novel strategy for the prevention and treatment of d
iseases in the future.